The features of the GBM microenvironment characterized by the IFNGrGS contain those of interest, such as IFNG response, activated but suppressed adaptive immune response, and immune checkpoint expression, making the gene signature potentially useful for screening ICB responders. This evidence concerns the gene IFNG and glioblastoma.